Freedman Financial Associates, Inc. Viatris Inc Transaction History

Freedman Financial Associates, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $8,218 - $10,135	-826 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$9.81 - $15.4 $774 - $1,216	79 Added 10.58%	826 $9,000
Q4 2021 Jan 14, 2022	SELL	$12.09 - $14.68 $1,728 - $2,099	-143 Reduced 16.07%	747 $10,000
Q3 2021 Oct 08, 2021	BUY	$13.25 - $15.13 $159 - $181	12 Added 1.37%	890 $12,000
Q2 2021 Jul 13, 2021	SELL	$12.97 - $16.15 $3,190 - $3,972	-246 Reduced 21.89%	878 $13,000
Q1 2021 May 17, 2021	SELL	$13.59 - $18.54 $3,601 - $4,913	-265 Reduced 19.08%	1,124 $16,000
Q4 2020 Feb 17, 2021	BUY	$14.3 - $18.74 $19,862 - $26,029	1,389 New	1,389 $26,000

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Freedman Financial Associates, Inc., based on Form 13F filings with the SEC.

Stay updated on Freedman Financial Associates, Inc. with notifications on news.